Bioadaptives, Inc.
BDPT· OTC
Source filing unavailable
| Metric | Q2 2018 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$412.78K | -$33.21K | -$109.36K | -$245.92K |
| EPS Diluted | -$0.02 | $0.00 | -$0.01 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioadaptives, Inc. · CIK 1575142 · Engraved from SEC EDGAR